Separating the Good from the Great: A Checklist for Evaluating a CRO for Rare Disease Studies

Small patient populations. Limited data on disease. Patient enrollment and retention challenges. Narrow site pools. These are some of the most common hurdles sponsors face in rare disease drug development. The right CRO partner can help turn these challenges into solutions.

When launching your next RFP, keep this checklist on hand to ensure you’re covering all of the bases when evaluating potential research partners for your rare disease study.

To read more, download the complete resource by submitting the form on this page.